SCHEMBL14725927

SCHEMBL14725927

NC(=O)CNC(=O)c1cccc(I)c1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TP53BP1 Q12888 1/20 0.54
HDAC1 Q13547 1/20 0.49
HDAC2 Q92769 1/20 0.49
SPHK2 Q9NRA0 1/20 0.47
MTOR P42345 3/20 0.46
GRM5 P41594 1/20 0.46
F2 P00734 1/20 0.44
MRGPRX4 Q96LA9 1/20 0.44
GAA P10253 1/20 0.44
KMT2A Q03164 1/20 0.44
HSD17B10 Q99714 1/20 0.44
KDM1A O60341 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGDS O60760 1/20 0.42
KAT6A Q92794 1/20 0.42
SIGMAR1 Q99720 1/20 0.41
FURIN P09958 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24990754 0.85 TP53BP1 (0.55) TP53BP1HDAC1HDAC2MTORGRM5
SCHEMBL2291348 0.83 TP53BP1 (0.57) TP53BP1HDAC1HDAC2MTORGRM5
SCHEMBL8298056 0.81 KDM4E (0.53) HDAC1SPHK2F2MRGPRX4GAA
SCHEMBL2293623 0.80 ALDH1A1 (0.63) TP53BP1HDAC1HDAC2MTORGRM5
SCHEMBL14725929 0.80 SPHK2 (0.47) HDAC2SPHK2MRGPRX4GAAKMT2A
SCHEMBL23714782 0.80 HDAC8 (0.59) KMT2ASMN1; SMN2
SCHEMBL13331944 0.80 PARP1 (0.58) KMT2AALDH1A1
SCHEMBL13381540 0.79 TP53BP1 (0.60) TP53BP1HDAC1HDAC2MTORGRM5
Hydrochloric Acid SCHEMBL7760549 0.79 TP53BP1 (0.59) TP53BP1HDAC1HDAC2SPHK2MTOR
SCHEMBL3090568 0.78 GAA (0.63) HDAC1HDAC2SPHK2GAAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130052132-A1 Method for Producing Radioactively Labeled Polypeptide ARKRAY, INC. (JP) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130052132-A1 Method for Producing Radioactively Labeled Polypeptide XPNPEP2, ARGLU1, XPNPEP1 TP53BP1 2386/4885HDAC1 1648/4885HDAC2 3099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.